Neonatal drug withdrawal syndrome Completed Phase 1 / 2 Trials for Buprenorphine (DB00921)

Also known as: Drug withdrawal syndrome neonatal / Neonatal Abstinence Syndrome / Neonatal withdrawal symptoms from maternal use of drugs of addiction / Drug withdrawal syndrome in newborn / Withdrawal syndrome neonatal / Neonatal abstinence syndrome (disorder)

IndicationStatusPhase
DBCOND0101857 (Neonatal drug withdrawal syndrome)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03608696Buprenorphine Pharmacometric Open Label Research Study of Drug ExposureTreatment